To investigate whether targeting SHIP/AKT signaling pathway is beneficial to primary cells of WS, we obtained WS fibroblasts (AG05229 and AG12797) and normal control fibroblast (AG08498) from cell bank. This evidence concerns the gene INPP5D and Werner syndrome.